Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study

The Journal of Clinical Endocrinology and Metabolism
J C LovejoyC Partington

Abstract

Abdominal fat distribution is influenced by androgen levels in both men and women. The purpose of this study was to assess the effects on fat distribution of administering nandrolone decanoate (ND; an anabolic steroid with weak androgenic activity) or spironolactone (SP; an antiandrogen) in obese postmenopausal women. The design was a randomized, placebo-controlled, 9-month trial with simultaneous calorie restriction for weight loss. Women in all three groups lost comparable amounts of weight, but the ND-treated women gained lean mass relative to the other two groups (P < 0.0005) and lost more body fat than women in the SP group (P < 0.01). The resting metabolic rate also increased slightly in the ND group. ND treatment produced a gain in visceral fat, as determined by computed tomography scan, and a relatively greater loss of sc abdominal fat. SP-treated women lost significantly less sc fat than the other two groups. Serum cholesterol decreased in the placebo group, but increased slightly in the other two groups (significant for SP vs. placebo, P < 0.05). High density lipoprotein cholesterol decreased significantly in the ND-treated women. There were no significant changes in fasting glucose or insulin sensitivity. We conclude...Continue Reading

Associated Clinical Trials

Citations

Jul 21, 2011·Journal of Nutrition and Metabolism·Betty N Wu, Anthony J O'Sullivan
Oct 1, 2009·The Journal of Clinical Endocrinology and Metabolism·Rita Rastogi KalyaniSherita Hill Golden
Jan 2, 2003·Journal of Endocrinological Investigation·R PasqualiA Gambineri
Aug 31, 2010·Reproduction : the Official Journal of the Society for the Study of Fertility·Christine M Burt Solorzano, Christopher R McCartney
Jun 13, 2012·The Journal of Clinical Endocrinology and Metabolism·Catherine KimElizabeth Barrett-Connor
Jun 12, 2009·Gender Medicine·Odette Evangelista, Mary Ann McLaughlin
Jun 12, 2009·Gender Medicine·Eliza B Geer, Wei Shen
May 27, 2008·Metabolism: Clinical and Experimental·Gerald B PhillipsSteven B Heymsfield
Jan 29, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Flavia FranconiWalter Malorni
May 12, 2007·Fertility and Sterility·Glenn D Braunstein
Dec 17, 2011·Journal of Clinical Pharmacology·Lauren Nicole BellUNKNOWN Consortium on Breast Cancer Pharmacogenomics (COBRA)
Nov 25, 2004·Best Practice & Research. Clinical Gastroenterology·L Van GaalH J Verkade
May 2, 2006·Fertility and Sterility·Renato Pasquali
Aug 11, 2007·Annales d'endocrinologie·W Arlt
Nov 22, 2008·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J C LovejoyUNKNOWN Stock Conference 2008 Working Group
May 21, 2013·Biochimica Et Biophysica Acta·Ursula A White, Yourka D Tchoukalova
May 4, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·Olaf Hiort
Jul 4, 2016·Journal of the American Society of Hypertension : JASH·Jie V ZhaoC Mary Schooling
May 6, 2016·Fundamental & Clinical Pharmacology·Denise G TerraTadeu U de Andrade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.